Mark D. Plinio is Chief Commercial Officer of Evelo Biosciences, Inc.. Currently has a direct ownership of 3,750 shares of EVLO, which is worth approximately $0. The most recent transaction as insider was on Jan 31, 2023, when has been sold 1,250 shares (Common Stock) at a price of $0.88 per share, resulting in proceeds of $1,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.75K
0% 3M change
0% 12M change
Total Value Held $0

Mark D. Plinio Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2023
BUY
Grant, award, or other acquisition
$1,100 $0.88 p/Share
1,250 Added 25.0%
3,750 Common Stock
Jul 29 2022
BUY
Grant, award, or other acquisition
$2,237 $1.79 p/Share
1,250 Added 33.33%
2,500 Common Stock
Jan 31 2022
BUY
Grant, award, or other acquisition
$5,000 $4.0 p/Share
1,250 Added 50.0%
1,250 Common Stock
MDP

Mark D. Plinio

Chief Commercial Officer
Cambridge, MA

Track Institutional and Insider Activities on EVLO

Follow Evelo Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EVLO shares.

Notify only if

Insider Trading

Get notified when an Evelo Biosciences, Inc. insider buys or sells EVLO shares.

Notify only if

News

Receive news related to Evelo Biosciences, Inc.

Track Activities on EVLO